المؤلفون: Martino EA; Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy., Palmieri S; Hematology Unit, Ospedale Cardarelli, Napoli, Italy., Galli M; Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni, Bergamo, Italy., Derudas D; Department of Hematology, Businco Hospital, Cagliari, Italy., Mina R; Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy., Della Pepa R; Department of Clinical Medicine and Surgery, Hematology Unit, University of Naples 'Federico II', Naples, Italy., Zambello R; Department of Medicine, University of Padova, Hematology Unit, Padova, Italy.; Veneto Institute of Molecular Medicine, Padova, Italy., Vigna E; Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy., Bruzzese A; Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy., Mangiacavalli S; Division of Hematology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy., Zamagni E; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy., Califano C; Onco-Hematology Unit, 'A. Tortora' Hospital, Pagani, Italy., Musso M; Department of Oncology, Onco-Hematology Unit and TMO U.O.C., Palermo, Italy., Conticello C; Division of Hematology, Azienda Policlinico-S. Marco, University of Catania, Catania, Italy., Cerchione C; Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Mele G; Department of Hematology, Hospital Perrino, Brindisi, Italy., Di Renzo N; Department of Hematology, Hospital Vito Fazzi, Lecce, Italy., Offidani M; Hematology Unit, AOU delle Marche, Ancona, Italy., Tarantini G; Hematology Unit, 'Dimiccoli' Hospital, Barletta (BAT), Italy., Casaluci GM; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Rago A; UOSD Ematologia, Rome, Italy., Ria R; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro Medical School, Internal Medicine 'G. Baccelli'; CITEL, Bari, Italy.; Interdepartmental Centre for Research in Telemedicine, University of Bari Aldo Moro, Bari, Italy., Uccello G; Hematology Department, G. Garibaldi Hospital, Catania, Italy., Barilà G; Hematology Unit, Ospedale San Bortolo, Vicenza, Italy., Palumbo G; Department of Hematology, Hospital University Riuniti, Foggia, Italy., Pettine L; Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy., Vincelli ID; Department of Hemato-Oncology and Radiotherapy, Hematology Unit, Great Metropolitan Hospital 'Bianchi-Melacrino-Morelli', Reggio Calabria, Italy., Brunori M; Internal Medicine, Ospedale Santa Croce, Fano, Italy., Accardi F; Department of Hematology I, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy., Amico V; UOSD Ematologia, AORN San Pio, Benevento, Italy., Amendola A; Hematology Unit, Azienda Ospedaliera Regionale 'San Carlo', Potenza, Italy., Fontana R; Hematology and Transplant Center, University Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Salerno, Italy., Bongarzoni V; Department of Hematology, San Giovanni-Addolorata Hospital, Rome, Italy., Rossini B; Hematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' Bari, Bari, Italy., Cotzia E; Section of Hematology- Ospedale E. Muscatello-Augusta, Siracusa, Italy., Gozzetti A; Hematology, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy., Rizzi R; Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico Bari, Bari, Italy.; Department of Precision and Regenerative Medicine and Ionian Area, 'Aldo Moro' University School of Medicine, Bari, Italy., Sgherza N; Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico Bari, Bari, Italy., Reddiconto G; Department of Hematology, Hospital Vito Fazzi, Lecce, Italy., Maroccia A; Hematology Unit - Ospedale dell'Angelo Azienda ULSS n.3 Serenissima, Venezia Mestre, Italy., Franceschini L; Lymphoproliferative Diseases Unit, Tor Vergata University Hospital, Rome, Italy., Bertuglia G; Dipartimento di Oncologia ed Ematologia SC Ematologia 1 A.O. Citta' della Salute e della Scienza di Torino P.O. Molinette, Torino, Italy., Nappi D; Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Barbieri E; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy., Gamberi B; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy., Petrucci MT; Department of Translational and Precision Medicine, Hematology Azienda Policlinico Umberto I Sapienza University of Rome, Rome, Italy., Di Raimondo F; Division of Hematology, Azienda Policlinico-S. Marco, University of Catania, Catania, Italy., Neri A; Scientific Directorate, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Morabito F; Gruppo Amici Dell'Ematologia Foundation-GrADE, Reggio Emilia, Italy., Musto P; Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico Bari, Bari, Italy.; Department of Precision and Regenerative Medicine and Ionian Area, 'Aldo Moro' University School of Medicine, Bari, Italy., Gentile M; Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.; Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy.

المصدر: Hematological oncology [Hematol Oncol] 2024 Jul; Vol. 42 (4), pp. e3290.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Multiple Myeloma*/mortality , Multiple Myeloma*/pathology , Dexamethasone*/administration & dosage , Dexamethasone*/adverse effects , Dexamethasone*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Thalidomide*/analogs & derivatives , Thalidomide*/administration & dosage , Thalidomide*/adverse effects , Thalidomide*/therapeutic use, Humans ; Male ; Female ; Aged ; Middle Aged ; Retrospective Studies ; Follow-Up Studies ; Aged, 80 and over ; Adult ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Drug Resistance, Neoplasm ; Survival Rate

المؤلفون: Gentile M; Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy; Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende. massim.gentile@tiscali.it., Vigna E; Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza., Palmieri S; Hematology Unit, Ospedale Cardarelli, Napoli., Galli M; Hematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale-Papa Giovanni XXIII, Bergamo., Derudas D; Department of Hematology, Businco Hospital, Cagliari., Mina R; Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino, Torino., Della Pepa R; Hematology Unit, Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples., Zambello R; University of Padova, Department of Medicine, Hematology Unit, Italy; Veneto Institute of Molecular Medicine, Padova., Martino EA; Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza., Bruzzese A; Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza., Mangiacavalli S; Hematology Division, Department of Hematology-Oncology, IRCCS Fondazione Policlinico San Matteo, Pavia., Zamagni E; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna., Califano C; Onco-Hematology Unit, 'A. Tortora' Hospital, Pagani., Musso M; Onco-Hematology Unit and TMO U.O.C., Departiment of Oncology, Palermo., Conticello C; Division of Hematology, Azienda Policlinico-S. Marco, University of Catania, Catania., Cerchione C; Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori'., Mele G; Department of Hematology, Hospital Perrino, Brindisi., Di Renzo N; Department of Hematology, Hospital Vito Fazzi, Lecce., Offidani M; Hematology Unit, AOU Ospedali Riuniti di Ancona, Ancona., Tarantini G; Hematology Unit, 'Dimiccoli' Hospital, Barletta (BAT)., Casaluci GM; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara., Rago A; Haematology Unit, ASL ROMA 1 Santo Spirito Hospital of Rome Rome Italy., Ria R; Department of Biomedical Science, Internal Medicine 'G. Baccelli', Policlinico, University of Bari 'Aldo Moro' Medical School, Bari., Uccello G; Hematology Department, G. Garibaldi Hospital, Catania., Barilà G; University of Padova, Department of Medicine, Hematology Unit, Italy; Veneto Institute of Molecular Medicine, Padova., Palumbo G; Department of Hematology, Hospital University Riuniti, Foggia., Pompa A; Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano., Vincelli D; Department of Hemato-Oncology and Radiotherapy, Hematology Unit, Great Metropolitan Hospital 'Bianchi-Melacrino-Morelli', Reggio Calabria., Brunori M; Internal Medicine, Ospedale S. Croce, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Fano., Accardi F; Department of Hematology I, Azienda Ospedaliera Ospedali Riuniti Villa Sofia- Cervello, Palermo., Amico V; Hematology Unit, AORN G Rummo, Benevento., Amendola A; Hematology Unit, Azienda Ospedaliera Regionale 'San Carlo', Potenza., Fontana R; Hematology and Transplant Center, University Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Salerno., Bongarzoni V; Department of Hematology San Giovanni-Addolorata Hospital Rome Italy., Rossini B; Haematology, Ospedale Giovanni Paolo II°, Bari., Cotzia E; Section of Hematology- Ospedale E. Muscatello-Augusta, Siracusa., Gozzetti A; Hematology, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena., Rizzi R; Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari 'Aldo Moro', Bari., Sgherza N; Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari 'Aldo Moro', Bari., Ferretti E; Scientific Directorate, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia., Bertuglia G; Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino, Torino., Nappi D; Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori'., Petrucci MT; Department of Translational and Precision Medicine, Hematology Azienda Policlinico Umberto I Sapienza University of Rome, Rome., Di Raimondo F; Division of Hematology, Azienda Policlinico-S. Marco, University of Catania, Catania., Neri A; Scientific Directorate, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia. antonino.neri@ausl.re.it., Morabito F; Biotechnology Research Unit, AO of Cosenza, Cosenza., Musto P; Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari 'Aldo Moro', Bari.

المصدر: Haematologica [Haematologica] 2024 Jan 01; Vol. 109 (1), pp. 245-255. Date of Electronic Publication: 2024 Jan 01.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/diagnosis , Multiple Myeloma*/drug therapy , Multiple Myeloma*/etiology, Humans ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Dexamethasone/therapeutic use ; Lenalidomide/therapeutic use ; Proteasome Inhibitors/therapeutic use ; Retrospective Studies ; Controlled Clinical Trials as Topic

المؤلفون: Mauro FR; Hematology, Department of Translational and Precision Medicine, Sapienza University. mauro@bce.uniroma1.it., Starza ID; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome; GIMEMA Foundation., Messina M; GIMEMA Foundation., Reda G; Hematology Department, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico of Milan., Trentin L; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua., Coscia M; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino., Sportoletti P; Department of Medicine and Surgery, Institute of Hematology, Centro di Ricerca Emato Oncologica (CREO), University of Perugia, Perugia., Orsucci L; Department of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino., Arena V; GIMEMA Foundation., Casaluci GM; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and AOU Maggiore della Carità, Novara., Marasca R; Hematology Unit, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia., Murru R; Hematology and Stem Cell Transplantation Unit, Ospedale A. Businco, ARNAS 'G. Brotzu', Cagliari., Laurenti L; Fondazione Policlinico Universitario A Gemelli, IRCCS., Ilariucci F; Division of Hematology, Hematology, Arcispedale Santa Maria Nuova, Reggio Emilia., Stelitano C; Department of Hematology, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria., Mannina D; Division of Hematology, Azienda Ospedaliera Papardo, Messina., Massaia M; Division of Hematology, Santa Croce e Carle Hospital, Via Michele Coppino 26, 12100 Cuneo., Rigolin GM; Hematology Section, St. Anna University Hospital, Ferrara., Scarfò L; Strategic Research Program on CLL, IRCCS Ospedale San Raffaele and Università Vita- Salute San Raffaele, Milan., Marchetti M; Hematology and Transplant Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, University of Eastern Pedemont, Alessandria., Levato L; Department of Hematology, Pugliese Ciaccio Hospital, Catanzaro., Tani M; Division of Hematology, Santa Maria delle Croci Hospital, Ravenna., Arcari A; Division of Hematology, Guglielmo da Saliceto Hospital, Piacenza., Musuraca G; Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori-IRST, Meldola., Deodato M; ASST Grande Ospedale Metropolitano Niguarda, Milan., Galieni P; Hematology, Mazzoni Hospital, Ascoli Piceno., Patrizi VB; Hematology Department, Umberto I Hospital, Nocera Inferiore (Salerno)., Gottardi D; A.O. Ordine Mauriziano di Torino., Liberati AM; Università degli Studi di Perugia, Azienda Ospedaliera Santa Maria di Terni, Terni., Giordano A; University of Bari 'Aldo Moro,' Hematology and Stem Cell Transplantation Unit, Department of Emergency and Organ Transplantation, Bari., Molinari MC; Hematology, Department of Translational and Precision Medicine, Sapienza University., Pietrasanta D; Hematology and Transplant Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, University of Eastern Pedemont, Alessandria., Mattiello V; Hematology Department, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico of Milan., Visentin A; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua., Vitale C; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino., Albano F; University of Bari 'Aldo Moro,' Hematology and Stem Cell Transplantation Unit, Department of Emergency and Organ Transplantation, Bari., Neri A; Hematology Department, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico of Milan., De Novi LA; Hematology, Department of Translational and Precision Medicine, Sapienza University., De Propris MS; Hematology, Department of Translational and Precision Medicine, Sapienza University., Nanni M; Hematology, Department of Translational and Precision Medicine, Sapienza University., Del Giudice I; Hematology, Department of Translational and Precision Medicine, Sapienza University., Guarini A; Hematology, Department of Translational and Precision Medicine, Sapienza University., Fazi P; GIMEMA Foundation., Vignetti M; GIMEMA Foundation., Piciocchi A; GIMEMA Foundation., Cuneo A; Hematology Section, St. Anna University Hospital, Ferrara., Foà R; Hematology, Department of Translational and Precision Medicine, Sapienza University.

المصدر: Haematologica [Haematologica] 2023 Aug 01; Vol. 108 (8), pp. 2091-2100. Date of Electronic Publication: 2023 Aug 01.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/diagnosis , Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell*/genetics , COVID-19*, Humans ; Middle Aged ; Rituximab/adverse effects ; Neoplasm, Residual/drug therapy ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bridged Bicyclo Compounds, Heterocyclic/adverse effects

المؤلفون: Arcari A; Hematology Unit, Ospedale Guglielmo da Saliceto, Piacenza, Italy., Tabanelli V; Division of Haematopathology, European Institute of Oncology IRCCS, Milan, Italy., Merli F; Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy., Marcheselli L; Fondazione Italiana Linfomi-Onlus, Modena, Italy., Merli M; Division of Hematology, Ospedale di Circolo and Fondazione Macchi, University of Insubria, Varese, Italy., Balzarotti M; Department of Medical Oncology and Hematology, IRCCS Humanitas Research Hospital, Milan, Italy., Zilioli VR; Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Fabbri A; Unit of Hematology, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Cavallo F; Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU Città della Salute e della Scienza di Torino, Torino, Italy., Casaluci GM; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Tucci A; Department of Hematology, ASST Spedali Civili, Brescia, Italy., Puccini B; Hematology Department, University of Florence and AOU Careggi, Florence, Italy., Pennese E; Lymphoma Unit, Department of Hematology, Ospedale Spirito Santo, Pescara, Italy., Di Rocco A; Department of Traslational and Precision Medicine, Sapienza University, Rome, Italy., Zanni M; Division of Hematology, A.O. SS Antonio e Biagio and Cesare Arrigo, Alessandria, Italy., Flenghi L; Division of Hematology, S. Maria della Misericordia Hospital, Perugia, Italy., Gini G; Clinic of Hematology, Azienda Ospedaliera Universitaria Ospedali Riuniti, Ancona, Italy., Sartori R; Onco Hematology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Chiappella A; Division of Hematology, Istituto Nazionale Tumori, Milan, Italy., Usai SV; Division of Hematology, Ospedale Oncologico Armando Businco, Cagliari, Italy., Tani M; Hematology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy., Marino D; Department of Clinical and Experimental Oncology, Medical Oncology 1, Veneto Institute of Oncology IOV-IRCCS Padova, Padova, Italy., Arcaini L; Department of Molecular Medicine, University of Pavia and Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Vallisa D; Hematology Unit, Ospedale Guglielmo da Saliceto, Piacenza, Italy., Spina M; Division of Medical Oncology and Immunerelated tumors, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

المصدر: British journal of haematology [Br J Haematol] 2023 May; Vol. 201 (4), pp. 653-662. Date of Electronic Publication: 2023 Feb 02.

نوع المنشور: Observational Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Hepatitis C, Chronic*/drug therapy , Hepatitis C*/drug therapy , Hepatitis C*/epidemiology , Lymphoma, Large B-Cell, Diffuse*, Aged ; Humans ; Hepacivirus/genetics ; Antiviral Agents/therapeutic use ; Prospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Rituximab/therapeutic use ; Doxorubicin/therapeutic use ; Vincristine/therapeutic use ; Cyclophosphamide/therapeutic use ; Prednisone/therapeutic use

المؤلفون: Arcaini L; Department of Molecular Medicine, University of Pavia Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia luca.arcaini@unipv.it., Rossi D; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara., Lucioni M; Department of Pathology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia., Nicola M; Department of Molecular Medicine, University of Pavia., Bruscaggin A; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara., Fiaccadori V; Department of Molecular Medicine, University of Pavia., Riboni R; Department of Pathology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia., Ramponi A; Division of Pathology, Department of Health Science, Amedeo Avogadro University of Eastern Piedmont, Novara., Ferretti VV; Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia., Cresta S; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara., Casaluci GM; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara., Bonfichi M; Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia., Gotti M; Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia., Merli M; Division of Hematology, Ospedale di Circolo e Fondazione Macchi, University of Insubria, Varese, Italy., Maffi A; Department of Molecular Medicine, University of Pavia., Arra M; Department of Molecular Medicine, University of Pavia., Varettoni M; Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia., Rattotti S; Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia., Morello L; Department of Molecular Medicine, University of Pavia., Guerrera ML; Department of Molecular Medicine, University of Pavia., Sciarra R; Department of Molecular Medicine, University of Pavia., Gaidano G; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara., Cazzola M; Department of Molecular Medicine, University of Pavia Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia., Paulli M; Department of Molecular Medicine, University of Pavia Department of Pathology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia.

المصدر: Haematologica [Haematologica] 2015 Feb; Vol. 100 (2), pp. 246-52. Date of Electronic Publication: 2014 Nov 07.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Hepatitis C/*genetics , Homeodomain Proteins/*genetics , Lymphoma, Large B-Cell, Diffuse/*genetics , Mutation/*genetics , Neoplasm Recurrence, Local/*genetics , Nuclear Proteins/*genetics , Receptor, Notch1/*genetics , Receptor, Notch2/*genetics, Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; DNA-Binding Proteins ; Female ; Follow-Up Studies ; Hepacivirus/isolation & purification ; Hepatitis C/mortality ; Hepatitis C/pathology ; Hepatitis C/virology ; Humans ; Lymphoma, Large B-Cell, Diffuse/mortality ; Lymphoma, Large B-Cell, Diffuse/pathology ; Lymphoma, Large B-Cell, Diffuse/virology ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/virology ; Polymerase Chain Reaction ; Prognosis ; RNA-Binding Proteins ; Survival Rate

المؤلفون: Rossi D; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont , Novara, Italy., Rasi S; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont , Novara, Italy., Spina V; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont , Novara, Italy., Bruscaggin A; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont , Novara, Italy., Monti S; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont , Novara, Italy., Cresta S; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont , Novara, Italy., Famà R; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont , Novara, Italy., Deambrogi C; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont , Novara, Italy., Greco M; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont , Novara, Italy., Fangazio M; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont , Novara, Italy., Ciardullo C; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont , Novara, Italy., Piranda D; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont , Novara, Italy., Casaluci GM; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont , Novara, Italy., Messina M; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University , Rome, Italy., Giudice ID; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University , Rome, Italy., Chiaretti S; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University , Rome, Italy., Marinelli M; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University , Rome, Italy., Guarini A; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University , Rome, Italy., Foà R; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy; Fondazione Eleonora Lorillard Spencer Cenci, Sapienza University, Rome, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont , Novara, Italy.

المصدر: Leukemia supplements [Leuk Suppl] 2012 Aug; Vol. 1 (Suppl 2), pp. S26-8. Date of Electronic Publication: 2012 Aug 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101589153 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2044-5210 (Print) Linking ISSN: 20445210 NLM ISO Abbreviation: Leuk Suppl Subsets: PubMed not MEDLINE